Moreover, multiple novel candidate biomarkers have been identified within known (lysosomal, inflammatory, mitochondrial dysfunction, LRRK2) and novel biological pathways associated with PD (metabolomics). The gene discussed is LRRK2; the disease is Parkinson disease.